Clinical trial
The COlorectal BReath Analysis (COBRA2) Study: Non-invasive Breath Testing to Detect Colorectal Cancer
NCT05844514 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The COlorectal BReath Analysis (COBRA2) Study: Non-invasive Breath Testing to Detect Colorectal Cancer
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 23, 2022
- Completion date
- December 1, 2026
- Enrollment
- 720 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer